23andMe, moving beyond consumer DNA tests, is building a clinical trial recruitment business

Consumer genetics giant 23andMe announced Thursday that it would move deeper into the business of clinical trial recruitment, partnering with a fast-growing startup to help match its customers with nearby study sites based on their diseases, demographics, and DNA. (Source: stanews.com)